PCN38 Physician-Specialty Cost Differences of Treating Non-Melanoma Skin Cancer (NMSC): An Update

Value in Health - United Kingdom
doi 10.1016/j.jval.2012.03.1155
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV

Related search

Pcn353 - Construct Validity of Eq-5d-3l in Non-Melanoma Skin Cancer (Nmsc)

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2018English

Photodynamic Therapy and Fluorescence Diagnosis of Non-Melanoma Skin Cancer

English

Melanoma Skin Cancer Detection

International Journal of Innovative Technology and Exploring Engineering
Mechanics of MaterialsElectronic EngineeringCivilStructural EngineeringElectricalComputer Science
2019English

Rosiglitazone May Reduce Non-Melanoma Skin Cancer Risk in Taiwanese

BMC Cancer
Cancer ResearchOncologyGenetics
2015English

Upregulation of Fanconi Anemia DNA Repair Genes in Melanoma Compared With Non-Melanoma Skin Cancer

Journal of Investigative Dermatology
BiochemistryDermatologyCell BiologyMolecular Biology
2011English

Lifetime Prevalence of Non-Melanoma and Melanoma Skin Cancer in Australian Recreational and Competitive Surfers

Photodermatology Photoimmunology and Photomedicine
Nuclear MedicineRadiologyImmunologyAllergyMedicineImagingDermatology
2016English

Non-Melanoma Skin Cancer Treated With HDR Valencia Applicator: Clinical Outcomes

Journal of Contemporary Brachytherapy
Nuclear MedicineRadiologyImagingOncology
2014English

Melanoma & Skin Cancer Free Communications

Australasian Journal of Dermatology
DermatologyMedicine
2018English

Patient and Physician Preferences for Treating Adjuvant Melanoma: A Discrete Choice Experiment

Journal of Cancer Therapy
2017English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy